FOXP3 and neoplasm: A recent study showed delayed tumor growth, decreased production of IL-10, IL-2, and TGF-β, and increased survival of mice after inoculation of the FOXP3-silenced B16F10 melanoma cell line compared to mice injected with the wild-type cell line [146].